- Home
- CPAC vs XNCR Comparison
CPAC vs XNCR Comparison
Compare CPAC & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CPAC | XNCR |
|---|---|---|
| Founded | 1949 | 1997 |
| Country | Peru | United States |
| Employees | N/A | N/A |
| Industry | Building Materials | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 905.9M | 1.0B |
| IPO Year | 2012 | 2013 |
Fundamental Metrics
Financial Performance| Metric | CPAC | XNCR |
|---|---|---|
| Price | $10.63 | $12.85 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 2 | 10 |
| Target Price | $10.15 | ★ $22.78 |
| AVG Volume (30 Days) | 34.5K | ★ 794.1K |
| Earning Date | 02-13-2026 | 02-26-2026 |
| Dividend Yield | ★ 5.46% | N/A |
| EPS Growth | ★ 20.27 | N/A |
| EPS | ★ 0.15 | N/A |
| Revenue | ★ $601,081,883.00 | $150,132,000.00 |
| Revenue This Year | $9.96 | $18.68 |
| Revenue Next Year | $1.70 | N/A |
| P/E Ratio | $14.09 | ★ N/A |
| Revenue Growth | 6.18 | ★ 38.16 |
| 52 Week Low | $5.10 | $6.92 |
| 52 Week High | $11.30 | $21.00 |
Technical Indicators
Market Signals| Indicator | CPAC | XNCR |
|---|---|---|
| Relative Strength Index (RSI) | 62.78 | 33.77 |
| Support Level | $10.14 | $13.77 |
| Resistance Level | $10.80 | $15.40 |
| Average True Range (ATR) | 0.34 | 0.79 |
| MACD | -0.10 | -0.18 |
| Stochastic Oscillator | 43.16 | 0.00 |
Price Performance
Historical ComparisonAbout CPAC Cementos Pacasmayo S.A.A. (Each representing five)
Cementos Pacasmayo SAA is a Peruvian cement company that produces, distributes, and sells cement and cement-related materials, such as concrete blocks and ready-mix concrete. The company's products are used in construction. It also produces and sells quicklime for use in mining operations. The company sells its products mainly in the northern part of Peru. It owns three cement production and transportation facilities. Its flagship Pacasmayo facility is located in the northwest region of Peru, while its new cement plant in Piura and smaller Rioja facility are located in the northeast region of Peru.
About XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.